As we reflect back on the just completed Q4 data analytics sector earnings season, we dig into the relative performance of Domo (NASDAQ:DOMO) and its peers.
Organizations generate a lot of data that is stored in silos, often in incompatible formats, making it slow and costly to extract actionable insights, which in turn drives demand for modern cloud-based data analysis platforms that can efficiently analyze the silo-ed data.
The 5 data analytics stocks we track reported a weak Q4; on average, revenues beat analyst consensus estimates by 3.05%, while on average next quarter revenue guidance was 0.72% under consensus. Tech multiples have reverted to the historical mean after reaching all time levels in early 2021 and data analytics stocks have not been spared, with share prices down 15.8% since the previous earnings results, on average.
Domo (NASDAQ:DOMO)
Founded by Josh James after selling his former business Omniture to Adobe, Domo (NASDAQ:DOMO) provides business intelligence software that allows managers to access and visualize critical business metrics in real-time, using their smartphones.
Domo reported revenues of $79.6 million, up 13.8% year on year, beating analyst expectations by 2.77%. It was a weak quarter for the company, with a full year guidance missing analysts' expectations.
"Domo helps companies of all sizes better leverage data so every employee can be a multiplier of business impact," said Josh James, Founder and CEO, Domo.
The stock is down 26.5% since the results and currently trades at $12.1.
Read our full report on Domo here, it's free.
Best Q4: Alteryx (NYSE:AYX)
Initially created as a way to organise census data for the government, Alteryx (NYSE:AYX) provides software that helps companies automate and analyse their internal data processes.
Alteryx reported revenues of $301.1 million, up 73.2% year on year, beating analyst expectations by 7.79%. It was a decent quarter for the company, with exceptional revenue growth but underwhelming guidance for the next year.
Alteryx delivered the strongest analyst estimates beat, fastest revenue growth, and highest full year guidance raise among its peers. The company added 18 customers to a total of 8,358. The stock is down 5.81% since the results and currently trades at $56.6.
Is now the time to buy Alteryx? Access our full analysis of the earnings results here, it's free.
Slowest Q4: Health Catalyst (NASDAQ:HCAT)
Founded by healthcare professionals Tom Burton and Steve Barlow in 2008, Health Catalyst (NASDAQ:HCAT) provides data and analytics technology to healthcare organizations, enabling them to improve care and lower costs.
Health Catalyst reported revenues of $69.2 million, up 6.87% year on year, beating analyst expectations by 1.32%. It was a weak quarter for the company, with full year guidance missing analysts' expectations and a decline in gross margin.
Health Catalyst had the slowest revenue growth in the group. The stock is down 19.9% since the results and currently trades at $11.2.
Read our full analysis of Health Catalyst's results here.
Palantir (NYSE:PLTR)
Started by Peter Thiel after seeing US defence agencies struggle in the aftermath of the 2001 terrorist attacks, Palantir (NYSE:PLTR) offers software as a service platform that helps government agencies and large enterprises use data to make better decisions.
Palantir reported revenues of $508.6 million, up 17.5% year on year, in line with analyst expectations. Despite the stock rising on the results, it was a weak quarter for the company, with revenue guidance for the next quarter and the full year missing analysts' expectations.
Palantir had the weakest performance against analyst estimates and weakest full year guidance update among the peers. The stock is up 5.86% since the results and currently trades at $8.04.
Read our full, actionable report on Palantir here, it's free.
Amplitude (NASDAQ:AMPL)
Born out of a failed voice recognition startup by founder Spenser Skates, Amplitude (NASDAQ:AMPL) is data analytics software helping companies improve and optimize their digital products.
Amplitude reported revenues of $65.3 million, up 32% year on year, beating analyst expectations by 2.63%. It was a weak quarter for the company, with full year guidance missing analysts' expectations.
The company added 81 customers to a total of 1,994. The stock is down 32.5% since the results and currently trades at $11.3.
Read our full, actionable report on Amplitude here, it's free.
The author has no position in any of the stocks mentioned